ELDN stock news
This page provides real-time market news, earnings updates, and company announcements related to Eledon Pharmaceuticals, Inc. (ELDN).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-04-23 15:37 EST
Eledon Pharmaceuticals to Participate in Leerink Partners 2026 Global Healthcare Conference
Finviz2026-03-04 21:09:08
Eledon Pharmaceuticals Announces Orphan Drug Designation Granted to Tegoprubart for the Prevention of Allograft Rejection in Liver Transplantation
Finviz2026-03-10 11:07:14
Eledon Announces Updated Data from Investigator-Initiated Islet Transplant Trial of Tegoprubart in Patients with Type 1 Diabetes at UChicago Medicine
Finviz2026-03-16 11:03:46
NewcelX Announces Pricing of $1.35 Million Equity Financing at 30% Premium Pricing
Finviz2026-04-01 11:25:07
ELDN stock chart
ELDN stock detailsELDN stock price change
On the last trading day, ELDN stock closed at 3.96 USD, with a price change of -4.35% for the day.
Trade stock perpsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more